PL2851075T3 - Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu - Google Patents
Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanuInfo
- Publication number
- PL2851075T3 PL2851075T3 PL13790955T PL13790955T PL2851075T3 PL 2851075 T3 PL2851075 T3 PL 2851075T3 PL 13790955 T PL13790955 T PL 13790955T PL 13790955 T PL13790955 T PL 13790955T PL 2851075 T3 PL2851075 T3 PL 2851075T3
- Authority
- PL
- Poland
- Prior art keywords
- unsaturated
- preparation containing
- carbamoylmorphinan
- derivative
- carbamoylmorphinan derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012110417 | 2012-05-14 | ||
| PCT/JP2013/063278 WO2013172297A1 (ja) | 2012-05-14 | 2013-05-13 | ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤 |
| EP13790955.2A EP2851075B1 (en) | 2012-05-14 | 2013-05-13 | Preparation containing 6,7-unsaturated-7-carbamoylmorphinan derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2851075T3 true PL2851075T3 (pl) | 2022-02-21 |
Family
ID=49583702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13790955T PL2851075T3 (pl) | 2012-05-14 | 2013-05-13 | Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US10952968B2 (pl) |
| EP (1) | EP2851075B1 (pl) |
| JP (1) | JP5818219B2 (pl) |
| CA (1) | CA2873961C (pl) |
| DK (1) | DK2851075T3 (pl) |
| ES (1) | ES2903149T3 (pl) |
| PL (1) | PL2851075T3 (pl) |
| TW (1) | TW201350120A (pl) |
| WO (1) | WO2013172297A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110325178B (zh) * | 2016-12-26 | 2022-05-13 | 盐野义制药株式会社 | 改善含量均一性的制剂的制造方法 |
| JP6131379B1 (ja) * | 2016-12-28 | 2017-05-17 | 森下仁丹株式会社 | ４，５−エポキシモルヒナン誘導体含有製剤 |
| EP4062973A4 (en) * | 2019-11-20 | 2023-11-29 | Shionogi & Co., Ltd | 6,7-unsaturated-7-carbamoyl morphinan derivative-containing solid formulation |
| WO2021172462A1 (ja) * | 2020-02-28 | 2021-09-02 | 塩野義製薬株式会社 | 術後の消化管の回復促進のための医薬組成物および方法 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4365060A (en) * | 1979-04-28 | 1982-12-21 | Shin-Etsu Chemical Co. Ltd. | Enterosoluble capsules |
| US4931286A (en) * | 1989-04-19 | 1990-06-05 | Aqualon Company | High gloss cellulose tablet coating |
| US5225201A (en) * | 1991-08-23 | 1993-07-06 | Minnesota Mining And Manufacturing Company | Salsalate tablet |
| US5395627A (en) * | 1992-09-04 | 1995-03-07 | Akzo N.V. | Pharmaceutical granulate |
| TW442301B (en) | 1995-06-07 | 2001-06-23 | Sanofi Synthelabo | Pharmaceutical compositions containing irbesartan |
| CN1352558B (zh) * | 1999-05-21 | 2012-06-13 | 橘生药品工业株式会社 | 即释型口服用药物组合物 |
| US6740339B1 (en) * | 1999-06-18 | 2004-05-25 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
| GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| CA2350195C (en) | 2000-12-20 | 2003-06-10 | Duchesnay Inc. | Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate |
| PE20030323A1 (es) | 2001-08-31 | 2003-05-12 | Novartis Ag | Composicion farmaceutica |
| US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
| PA8576201A1 (es) | 2002-07-10 | 2004-05-26 | Pfizer Prod Inc | Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco |
| CA2509620A1 (en) * | 2002-12-17 | 2004-07-01 | Wakunaga Pharmaceutical Co., Ltd. | Light-shielding agent and film-forming composition |
| ES2335008T3 (es) * | 2003-04-24 | 2010-03-18 | Jagotec Ag | Comprimido con nucleo coloreado. |
| MXPA05011446A (es) * | 2003-04-24 | 2006-05-31 | Jagotec Ag | Tableta con liberacion retardada con geometria de nucleo definida. |
| NZ544585A (en) | 2003-07-11 | 2008-04-30 | Hoffmann La Roche | Saquinavir mesylate oral dosage form |
| WO2006038661A1 (ja) | 2004-10-06 | 2006-04-13 | Eisai R & D Management Co., Ltd. | 医薬組成物及びその製造方法、並びに医薬組成物におけるジヒドロピリジン系化合物の安定化方法 |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| JP4214128B2 (ja) | 2005-04-27 | 2009-01-28 | 大日本住友製薬株式会社 | 光安定性の向上した組成物 |
| WO2006126529A1 (ja) * | 2005-05-25 | 2006-11-30 | Shionogi & Co., Ltd. | ６，７－不飽和－７－カルバモイル置換モルヒナン誘導体 |
| US20070077300A1 (en) * | 2005-09-30 | 2007-04-05 | Wynn David W | Oral compositions containing a salivation inducing agent |
| US8637078B2 (en) * | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
| KR20080080318A (ko) * | 2005-12-20 | 2008-09-03 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 지용성 약물을 함유하는 구강내 속붕정 |
| AR065698A1 (es) * | 2007-03-13 | 2009-06-24 | Takeda Pharmaceutical | Preparacion solida |
| ATE550023T1 (de) | 2007-04-26 | 2012-04-15 | Toray Industries | Stabile feste zubereitung mit 4,5- epoxymorphinanderivat |
| WO2008143240A1 (ja) * | 2007-05-21 | 2008-11-27 | Toray Industries, Inc. | 特定の有機酸を含有する経口製剤並びに経口製剤の溶出性及び化学的安定性の改善方法 |
| EA200901591A1 (ru) * | 2007-06-13 | 2010-06-30 | Медитор Фармасьютикалс Лтд. | Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом |
| CL2008003230A1 (es) * | 2007-11-01 | 2009-11-27 | Sanofi Aventis Healthcare Pty Ltd | Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta. |
| WO2009087690A2 (en) * | 2008-01-11 | 2009-07-16 | Jubilant Organosys Limited | Multiparticulate extended release pharmaceutical composition of carbamazepine and process for manufacturing the same |
| KR20100121483A (ko) | 2008-02-11 | 2010-11-17 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | 용출성이 개선된 정제 |
| TW201014850A (en) * | 2008-09-25 | 2010-04-16 | Takeda Pharmaceutical | Solid pharmaceutical composition |
| DK2356989T3 (en) | 2008-10-24 | 2018-05-07 | Toray Industries | Stable tablet containing 4,5-epoxymorphinane derivative |
| WO2010110436A1 (ja) * | 2009-03-27 | 2010-09-30 | 杏林製薬株式会社 | 塩基性添加剤を含有するマトリックス型徐放性製剤 |
| JP5452050B2 (ja) | 2009-03-27 | 2014-03-26 | 杏林製薬株式会社 | イミダフェナシンを含有する口腔内崩壊錠 |
| JP5644167B2 (ja) | 2009-04-21 | 2014-12-24 | 大正製薬株式会社 | 溶出改善されたケトチフェン又はその塩を含有する固形製剤 |
| MX2012005163A (es) * | 2009-11-06 | 2012-11-22 | Infinity Pharmaceuticals Inc | Formulaciones orales de un inhibidor de la ruta de hedgehog. |
| JP2011105694A (ja) | 2009-11-12 | 2011-06-02 | Takada Seiyaku Kk | オロパタジン経口固形組成物 |
| WO2011087705A2 (en) * | 2009-12-22 | 2011-07-21 | Fmc Corporation | Fine particle croscarmellose and uses thereof |
| BR112013011593B1 (pt) | 2010-11-12 | 2022-02-22 | Shionogi & Co., Ltd | Sal de ácido p-toluenossulfônico |
| WO2014078912A1 (en) * | 2012-11-26 | 2014-05-30 | Progel Pty Ltd | Coating composition |
-
2013
- 2013-05-13 ES ES13790955T patent/ES2903149T3/es active Active
- 2013-05-13 US US14/401,388 patent/US10952968B2/en active Active
- 2013-05-13 DK DK13790955.2T patent/DK2851075T3/da active
- 2013-05-13 PL PL13790955T patent/PL2851075T3/pl unknown
- 2013-05-13 EP EP13790955.2A patent/EP2851075B1/en active Active
- 2013-05-13 CA CA2873961A patent/CA2873961C/en active Active
- 2013-05-13 JP JP2014515611A patent/JP5818219B2/ja active Active
- 2013-05-13 WO PCT/JP2013/063278 patent/WO2013172297A1/ja not_active Ceased
- 2013-05-14 TW TW102117071A patent/TW201350120A/zh unknown
-
2018
- 2018-10-12 US US16/158,786 patent/US11116727B2/en active Active
-
2021
- 2021-01-25 US US17/156,892 patent/US12350377B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2851075B1 (en) | 2021-12-01 |
| US20150216804A1 (en) | 2015-08-06 |
| CA2873961C (en) | 2017-09-26 |
| JPWO2013172297A1 (ja) | 2016-01-12 |
| US12350377B2 (en) | 2025-07-08 |
| EP2851075A4 (en) | 2015-10-21 |
| WO2013172297A1 (ja) | 2013-11-21 |
| EP2851075A1 (en) | 2015-03-25 |
| DK2851075T3 (da) | 2022-01-31 |
| CA2873961A1 (en) | 2013-11-21 |
| US11116727B2 (en) | 2021-09-14 |
| US20190046452A1 (en) | 2019-02-14 |
| TW201350120A (zh) | 2013-12-16 |
| US10952968B2 (en) | 2021-03-23 |
| ES2903149T3 (es) | 2022-03-31 |
| JP5818219B2 (ja) | 2015-11-18 |
| US20210145753A1 (en) | 2021-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2875029B8 (en) | 5,5-heteroaromatic anti-infective compounds | |
| ZA201409248B (en) | Novel indanesulfamide derivative | |
| ZA201306229B (en) | Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines | |
| GB201222141D0 (en) | Further addtions 2 | |
| GB201214120D0 (en) | Yota 070812 | |
| PL2851075T3 (pl) | Preparat zawierający pochodną 6,7-nienasyconego-7-karbamoilomorfinanu | |
| SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors | |
| TWM432338U (en) | M1010701_3919 | |
| TWM432495U (en) | M1010701_3919 | |
| GB201200518D0 (en) | Wizz-through 2 (cielings) | |
| GB201200323D0 (en) | Easihang 45?/90? | |
| GB201220196D0 (en) | Magno-rebel 1 | |
| GB201220558D0 (en) | Novel compounds 1 | |
| GB201214054D0 (en) | Pakaging 0 | |
| GB201208532D0 (en) | SockScreen 2 | |
| GB201210424D0 (en) | Poop - pole N?2 | |
| GB201206581D0 (en) | CityJaw 1830 | |
| GB201206730D0 (en) | Novel compounds 1 | |
| GB201200834D0 (en) | Vinsole 3 | |
| GB201210088D0 (en) | Odontalgic preparation | |
| TWM432299U (en) | M1010701_3919 | |
| TWM432309U (en) | M1010701_3919 | |
| TWM432296U (en) | M1010701_3919 | |
| TWM432298U (en) | M1010701_3919 | |
| TWM432520U (en) | M1010701_3919 |